BC is classified into three main tumor subtypes rooted in enhancement in expression of either progesterone receptor (PR) or estrogen receptor (ER), and/or epidermal growth factor receptor 2 (ERBB2) gene mutation [10,11,12,13,14]. This evidence concerns the gene ERBB2 and neoplasm.